Psoriasis and Hypertension Severity: Results from a Case-Control Study
Open Access
- 29 March 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (3), e18227
- https://doi.org/10.1371/journal.pone.0018227
Abstract
Epidemiologic studies have provided new insights into the association between psoriasis and cardiovascular diseases. Previous population studies have examined hypertension frequency in psoriasis patients. However, the relationship between severity of hypertension and psoriasis has not been characterized. We sought to investigate whether patients with psoriasis have more difficult-to-manage hypertension compared to non-psoriatic hypertensive patients. We performed a case-control study using the University of California Davis electronic medical records. The cases were defined as patients diagnosed with both psoriasis and hypertension, and controls were defined as patients with hypertension and without psoriasis. In this identified population, 835 cases were matched on age, sex, and body mass index (BMI) to 2418 control patients. Treatment with multiple anti-hypertensives was significantly associated with the presence of psoriasis using univariate (p<0.0001) and multivariable analysis, after adjusting for diabetes, hyperlipidemia, and race (p<0.0001). Compared to hypertensive patients without psoriasis, psoriasis patients with hypertension were 5 times more likely to be on a monotherapy antihypertensive regimen (95% CI 3.607.05), 9.5 times more likely to be on dual antihypertensive therapy (95% CI 6.68–13.65), 16.5 times more likely to be on triple antihypertensive regimen (95% CI 11.01–24.84), and 19.9 times more likely to be on quadruple therapy or centrally-acting agent (95% CI 10.58–37.33) in multivariable analysis after adjusting for traditional cardiac risk factors. Psoriasis patients appear to have more difficult-to-control hypertension compared to non-psoriatic, hypertensive patients.Keywords
This publication has 30 references indexed in Scilit:
- Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research DatabaseEuropean Heart Journal, 2009
- Psoriasis and Atherothrombotic Diseases: Disease-Specific and Non–Disease-Specific Risk FactorsSeminars in Thrombosis and Hemostasis, 2009
- Psoriasis and the Risk of Diabetes and HypertensionArchives of Dermatology, 2009
- Incidence and Risk Factors for Psoriasis in the General PopulationArchives of Dermatology, 2007
- The Risk of Mortality in Patients With PsoriasisArchives of Dermatology, 2007
- The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: A case-control studyJournal of the American Academy of Dermatology, 2007
- Prevalence of cardiovascular risk factors in patients with psoriasisJournal of the American Academy of Dermatology, 2006
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchiv für dermatologische Forschung, 2006
- Weight Loss and the Renin-Angiotensin-Aldosterone SystemHypertension, 2005
- T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulationNature Immunology, 2004